Emergent BioSolutions (EBS) Retained Earnings (2010 - 2026)
Emergent BioSolutions (EBS) reported Retained Earnings of -$333.2 million for Q2 2026, compared with -$156.4 million a year earlier.
Powered by 
Analysis
Emergent BioSolutions (EBS) Retained Earnings (2010 - 2026) Analysis & Trends
At the end of FY2025, Emergent BioSolutions posted Retained Earnings of -$159.8 million.
- By year, Retained Earnings came in at -$212.4 million in FY2024, -$21.8 million in FY2023, $738.7 million in FY2022 (-22.3%) and $950.3 million in FY2021 (+30.7%).
- The Q2 2026 figure ranks as the lowest quarterly Retained Earnings in data going back to Q4 2010.
- The high point for year-over-year Retained Earnings in five years was Q3 2021 (growth of 41.9%); the low point was Q3 2023 (a decline of 96.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at -$153 million (Q1 2026), -$159.8 million (Q4 2025) and -$105.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 31.89 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 171.67 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | -17.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 63.27 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 12.59 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | -22.28 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 2.20 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 112.09 Bn |
| 10 | Emergent BioSolutions | 325.34 Mn | -425.56 Mn | 137.20 Mn | -333.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -333.20 Mn |
| Mar 31, 2026 | -153.00 Mn |
| Dec 31, 2025 | -159.80 Mn |
| Sep 30, 2025 | -105.20 Mn |
| Jun 30, 2025 | -156.40 Mn |
| Mar 31, 2025 | -144.40 Mn |
| Dec 31, 2024 | -212.40 Mn |
| Sep 30, 2024 | -181.10 Mn |
| Jun 30, 2024 | -295.90 Mn |
| Mar 31, 2024 | -12.80 Mn |
| Dec 31, 2023 | -21.80 Mn |
| Sep 30, 2023 | 27.70 Mn |
| Jun 30, 2023 | 289.70 Mn |
| Mar 31, 2023 | 551.00 Mn |
| Dec 31, 2022 | 738.70 Mn |
| Sep 30, 2022 | 805.70 Mn |
| Jun 30, 2022 | 897.70 Mn |
| Mar 31, 2022 | 954.10 Mn |
| Dec 31, 2021 | 950.30 Mn |
| Sep 30, 2021 | 768.50 Mn |
API Access
Emergent BioSolutions Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();